Exchange: NASDAQ·Updated 07:00 AM EDT
ASND logo

ASND Ascendis Pharma

$273.89
$2.77
(1.02%)
Pre-Market
Prev Close $271.12
Reported EarningsAug 13
Mkt Cap$16.67B
Vol391.00

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
53

Neutral Sentiment

How do you feel about ASND?

Advertisement|Remove ads.